Terminology Service < Semantic Lookup Platform

All terms in HP

Label	Id	Description
Folate-responsive megaloblastic anemia	HP_0004851	[A type of megaloblastic anemia (i.e., anemia characterized by the presence of erythroblasts that are larger than normal) that improves upon the administration of folate.]
Megaloblastic anemia	HP_0001889	[Anemia characterized by the presence of erythroblasts that are larger than normal (megaloblasts).]
phosphate(3-)	CHEBI_18367	[A phosphate ion that is the conjugate base of hydrogenphosphate.]
phosphate ion	CHEBI_35780	[A phosphorus oxoanion that is the conjugate base of phosphoric acid.]
hydrogenphosphate	CHEBI_43474	[A phosphate ion that is the conjugate base of dihydrogenphosphate.]
type 2 immune response	GO_0042092	[An immune response which is associated with resistance to extracellular organisms such as helminths and pathological conditions such as allergy, which is orchestrated by the production of particular cytokines, most notably IL-4, IL-5, IL-10, and IL-13, by any of a variety of cell types including T-helper 2 cells, eosinophils, basophils, mast cells, and nuocytes, resulting in enhanced production of certain antibody isotypes and other effects.]
immune response	GO_0006955	[Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.]
Amegakaryocytic thrombocytopenia	HP_0004859	[Thrombocytopenia related to lack of or severe reduction in the count of megakaryocytes.]
Pulmonary embolism	HP_0002204	[An embolus (that is, an abnormal particle circulating in the blood) located in the pulmonary artery and thereby blocking blood circulation to the lung. Usually the embolus is a blood clot that has developed in an extremity (for instance, a deep venous thrombosis), detached, and traveled through the circulation before becoming trapped in the pulmonary artery.]
Abnormality of pulmonary circulation	HP_0030875	[A functional anomaly of that portion of the cardiosvascular system that carries deoxygenated blood from the heart to the lungs and returns oxygenated blood back to the heart.]
Respiratory paralysis	HP_0002203	[Inability to move the muscles of respiration.]
Weakness of muscles of respiration	HP_0004347	[Reduced function of the muscles required to generate subatmospheric pressure in the thoracic cavity during breathing: the diaphragm, the external intercostal and the interchondral part of the internal intercostal muscles.]
Paralysis	HP_0003470	[Paralysis of voluntary muscles means loss of contraction due to interruption of one or more motor pathways from the brain to the muscle fibers. Although the word paralysis is often used interchangeably to mean either complete or partial loss of muscle strength, it is preferable to use paralysis or plegia for complete or severe loss of muscle strength, and paresis for partial or slight loss. Motor paralysis results from deficits of the upper motor neurons (corticospinal, corticobulbar, or subcorticospinal). Motor paralysis is often accompanied by an impairment in the facility of movement.]
Pulmonary fibrosis	HP_0002206	[Replacement of normal lung tissues by fibroblasts and collagen.]
beta-alanine zwitterion	CHEBI_57966	[Zwitterionic form of beta-alanine arising from transfer of a proton from the carboxy to the amino group; major species at pH 7.3.]
amino acid zwitterion	CHEBI_35238	[The zwitterionic form of an amino acid having a negatively charged carboxyl group and a positively charged amino group.]
beta-alanine	CHEBI_16958	[A naturally-occurring beta-amino acid comprising propionic acid with the amino group in the 3-position.]
Impaired ADP-induced platelet aggregation	HP_0004866	[Abnormal platelet response to ADP as manifested by reduced or lacking aggregation of platelets upon addition of ADP.]
Impaired platelet aggregation	HP_0003540	[An impairment in the rate and degree to which platelets aggregate after the addition of an agonist that stimulates platelet clumping. Platelet aggregation is measured using aggregometer to measure the optical density of platelet-rich plasma, whereby platelet aggregation causes the plasma to become more transparent.]
Recurrent respiratory infections	HP_0002205	[An increased susceptibility to respiratory infections as manifested by a history of recurrent respiratory infections.]